Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Jones

Showing results (491-500 of 492) with videos related to

Pageof 50
Sort By:
You have reached the last page of results.This site can display upto 492 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2018
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)T R Cottrell, E D Thompson, P M Forde, et al.
The New England Journal of Medicine|December 12, 2013
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2J Nangalia, C E Massie, E J Baxter, et al.
Pageof 50

Showing results (491-500 of 492) with videos related to

Sort By:
Pageof 50
You have reached the last page of results.This site can display upto 492 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2018
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)T R Cottrell, E D Thompson, P M Forde, et al.
The New England Journal of Medicine|December 12, 2013
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2J Nangalia, C E Massie, E J Baxter, et al.
Pageof 50